​PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the Overlooked Small Cap Stocks to Buy Now. Wall Street is positive ...
Full-year 2025 revenue guidance was updated to approximately $323 million, reflecting 44% growth compared to 2024. This includes US system revenue of $95 million, driven by greenfield sales and some ...
SAN JOSE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative ...
Detailed price information for Procept Biorobotics Corp (PRCT-Q) from The Globe and Mail including charting and trades.
On Thursday, Spruce Point Capital released a detailed report on PROCEPT BioRobotics (NASDAQ:PRCT), raising concerns about the claims surrounding its market potential and growth prospects, suggesting ...
PROCEPT BioRobotics (PRCT) remains unprofitable, with net losses deepening at a rate of 14.1% per year over the past five years and no improvement in net profit margin. While current numbers continue ...
SAN JOSE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (“the Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology ...
Without a specific news announcement driving the move, PROCEPT BioRobotics (PRCT) has drawn investor attention after a recent mix of short term gains and longer term weakness in its share price ...
Procept makes the AquaBeam Robotic System, which is designed to be used in performing minimally invasive urology surgeries. The company's first-quarter results were positive, for the most part.
We recently compiled a list of the 20 Hidden Gem AI Stocks. In this article, we are going to take a look at where PROCEPT BioRobotics Corporation (NASDAQ:PRCT) stands against the other hidden gem AI ...
The company makes a surgical robotic system for minimally invasive urologic surgery and its shares have dropped by 46% since it raised $164 million in a September IPO. Procept Biorobotics Inc., whose ...